相关实验视频
Updated: Jul 12, 2025

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.6K
铁氧化物纳米颗粒用于癌症治疗:细胞反应和提高辐射敏感性的潜力
Maria V Shestovskaya1, Anna L Luss1,2, Olga A Bezborodova3
1Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Schukinskaya st. 5/1, Moscow 119435, Russia.
Pharmaceutics
|October 28, 2023
概括
磁铁氧化物纳米粒子 (IONPs) 增强瘤对放射治疗的反应. 这篇评论探讨了IONP的情况.
科学领域:
- 纳米医学是一种纳米医学.
- 辐射瘤学 辐射瘤学
- 材料科学 材料科学 材料科学
背景情况:
- 辐射敏感化通过增加瘤细胞对电离辐射的敏感性来提高辐射疗法的疗效.
- 金属氧化物纳米粒子正在探索放射敏感化,但机制尚未完全理解.
- 磁铁氧化物纳米粒子 (IONPs) 由于其独特的特性,显示出有希望的结果.
研究的目的:
- 通过IONPs审查放射敏感化的分子机制.
- 探索改善IONP治疗功效的修改方法.
主要方法:
- 对IONP作为放射敏感剂的研究的文献综述.
- 对IONP的物理化学特征和反应性的分析.
- 研究涉及IONP介导放射敏感化的分子途径.
主要成果:
- IONP具有独特的物理化学特性,有利于辐射敏感化.
- 各种分子机制有助于IONP诱导的辐射敏感化效应.
- 表面修改和功能化可以提高IONP的治疗潜力.
结论:
- IONPs代表了一个有前途的放射性敏感剂类别.
- 对IONP机制和修改的进一步研究可以优化癌症治疗.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Electron Transport Chain: Complex I and II
14.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.2K

